Fapon COVID-19 New Products, Anti-SARS-CoV-2 Fully Human RBD IgG Quality Controls

Fapon Anti-SARS-CoV-2 Fully Human RBD IgG Quality Control

Fapon Anti-SARS-CoV-2 Fully Human RBD IgG Recombinant Antibody is produced by natural human infection with HIGH SENSITIVITY IN PERFORMANCE. By isolating PBMC (Peripheral Blood Mononuclear Cell) from the blood of SARS-CoV-2 recovered patients, cells that have positive reactions to RBD antigens are selected to obtain IgG recombinant antibodies through gene recombination and cloning.

The reactivity of Fapon IgG recombinant antibody to RBD is more consistent with the reactivity of the serum of SARS-CoV-2 patients, which OUTPERFORMS OTHER HUMANIZED ANTIBODIES OBTAINED BY IMMUNIZED MICE WITH RECOMBINANT ANTIGENS in the market as their consistency to infected serum are relatively lower. After validation by different parties, Fapon IgG quality control is proved to be stable and can be applied in COVID-19 IgG antibody detection.